US Stock MarketDetailed Quotes

IRD Opus Genetics

Watchlist
  • 1.130
  • -0.020-1.74%
Close Feb 14 16:00 ET
  • 1.160
  • +0.030+2.65%
Post 20:01 ET
35.67MMarket Cap-1.04P/E (TTM)

Opus Genetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-67.60%3.87M
-69.73%1.11M
-2.17%1.71M
-52.20%19.05M
-95.76%1.69M
11.94M
3.67M
1.75M
6,665.70%39.85M
39.85M
Operating revenue
-67.60%3.87M
-69.73%1.11M
-2.17%1.71M
-52.20%19.05M
-95.76%1.69M
--11.94M
--3.67M
--1.75M
6,665.70%39.85M
--39.85M
Cost of revenue
Gross profit
Operating expense
114.02%11.88M
4.16%9.44M
19.53%9.42M
36.94%29.61M
26.24%7.12M
22.28%5.55M
83.54%9.06M
21.08%7.88M
-7.17%21.62M
-8.29%5.64M
Selling and administrative expenses
40.83%2.89M
-22.72%3.35M
104.38%4.67M
64.52%11.96M
59.64%3.28M
20.67%2.06M
144.37%4.34M
31.62%2.29M
-10.49%7.27M
45.26%2.05M
-General and administrative expense
40.83%2.89M
-22.72%3.35M
----
64.52%11.96M
--3.28M
--2.06M
--4.34M
----
--7.27M
----
Research and development costs
157.07%8.98M
28.86%6.09M
-15.12%4.75M
22.97%17.65M
7.11%3.84M
23.25%3.49M
49.37%4.72M
17.25%5.6M
-5.39%14.36M
-24.28%3.59M
Operating profit
-225.41%-8.01M
-54.54%-8.33M
-25.72%-7.71M
-157.96%-10.56M
-115.87%-5.43M
240.72%6.39M
-9.13%-5.39M
5.79%-6.13M
180.27%18.23M
656.26%34.21M
Net non-operating interest income expense
137.65%500K
63.49%600K
-14,655.56%-1.33M
0
-1.33M
7,440.00%367K
-350.00%-9K
0
Non-operating interest income
--500K
----
63.49%600K
----
----
----
----
--367K
----
----
Non-operating interest expense
--0
----
----
--0
---1.33M
--1.33M
----
----
350.00%9K
--0
Total other finance cost
----
----
----
--1.33M
----
----
----
----
----
----
Other net income (expense)
-103.29%-17K
31.54%563K
107.41%2K
13,792.86%1.92M
1,273.91%632K
7,285.71%517K
2,753.33%428K
67.07%-27K
99.96%-14K
128.57%46K
Gain on sale of security
----
----
----
--80K
--19K
--61K
----
---27K
----
----
Other non- operating income (expenses)
-103.73%-17K
31.54%563K
--2K
13,221.43%1.84M
1,232.61%613K
6,414.29%456K
2,753.33%428K
----
91.08%-14K
128.57%46K
Income before tax
-235.00%-7.53M
-56.52%-7.77M
-22.71%-7.11M
-154.79%-9.97M
-114.00%-4.8M
223.04%5.58M
-0.69%-4.96M
12.19%-5.79M
132.11%18.2M
642.63%34.26M
Income tax
0
0
0
-96.19%12K
-100.63%-2K
14K
0
0
315K
315K
Net income
-235.34%-7.53M
-56.52%-7.77M
-22.71%-7.11M
-155.83%-9.99M
-114.13%-4.8M
222.73%5.56M
-0.69%-4.96M
12.19%-5.79M
131.55%17.89M
637.64%33.94M
Net income continuous Operations
-235.34%-7.53M
-56.52%-7.77M
-22.71%-7.11M
-155.83%-9.99M
-114.13%-4.8M
222.73%5.56M
-0.69%-4.96M
12.19%-5.79M
131.55%17.89M
637.64%33.94M
Minority interest income
Net income attributable to the parent company
-235.34%-7.53M
-56.52%-7.77M
-22.71%-7.11M
-155.83%-9.99M
-114.13%-4.8M
222.73%5.56M
-0.69%-4.96M
12.19%-5.79M
131.55%17.89M
637.64%33.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-235.34%-7.53M
-56.52%-7.77M
-22.71%-7.11M
-155.83%-9.99M
-114.13%-4.8M
222.73%5.56M
-0.69%-4.96M
12.19%-5.79M
131.55%17.89M
637.64%33.94M
Basic earnings per share
-211.54%-0.29
-25.00%-0.3
-3.57%-0.29
-151.11%-0.46
-112.88%-0.21
218.18%0.26
4.00%-0.24
20.00%-0.28
123.56%0.9
565.71%1.63
Diluted earnings per share
-216.00%-0.29
-25.00%-0.3
-3.57%-0.29
-152.87%-0.46
-113.29%-0.21
213.64%0.25
4.00%-0.24
20.00%-0.28
122.77%0.87
551.43%1.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -67.60%3.87M-69.73%1.11M-2.17%1.71M-52.20%19.05M-95.76%1.69M11.94M3.67M1.75M6,665.70%39.85M39.85M
Operating revenue -67.60%3.87M-69.73%1.11M-2.17%1.71M-52.20%19.05M-95.76%1.69M--11.94M--3.67M--1.75M6,665.70%39.85M--39.85M
Cost of revenue
Gross profit
Operating expense 114.02%11.88M4.16%9.44M19.53%9.42M36.94%29.61M26.24%7.12M22.28%5.55M83.54%9.06M21.08%7.88M-7.17%21.62M-8.29%5.64M
Selling and administrative expenses 40.83%2.89M-22.72%3.35M104.38%4.67M64.52%11.96M59.64%3.28M20.67%2.06M144.37%4.34M31.62%2.29M-10.49%7.27M45.26%2.05M
-General and administrative expense 40.83%2.89M-22.72%3.35M----64.52%11.96M--3.28M--2.06M--4.34M------7.27M----
Research and development costs 157.07%8.98M28.86%6.09M-15.12%4.75M22.97%17.65M7.11%3.84M23.25%3.49M49.37%4.72M17.25%5.6M-5.39%14.36M-24.28%3.59M
Operating profit -225.41%-8.01M-54.54%-8.33M-25.72%-7.71M-157.96%-10.56M-115.87%-5.43M240.72%6.39M-9.13%-5.39M5.79%-6.13M180.27%18.23M656.26%34.21M
Net non-operating interest income expense 137.65%500K63.49%600K-14,655.56%-1.33M0-1.33M7,440.00%367K-350.00%-9K0
Non-operating interest income --500K----63.49%600K------------------367K--------
Non-operating interest expense --0----------0---1.33M--1.33M--------350.00%9K--0
Total other finance cost --------------1.33M------------------------
Other net income (expense) -103.29%-17K31.54%563K107.41%2K13,792.86%1.92M1,273.91%632K7,285.71%517K2,753.33%428K67.07%-27K99.96%-14K128.57%46K
Gain on sale of security --------------80K--19K--61K-------27K--------
Other non- operating income (expenses) -103.73%-17K31.54%563K--2K13,221.43%1.84M1,232.61%613K6,414.29%456K2,753.33%428K----91.08%-14K128.57%46K
Income before tax -235.00%-7.53M-56.52%-7.77M-22.71%-7.11M-154.79%-9.97M-114.00%-4.8M223.04%5.58M-0.69%-4.96M12.19%-5.79M132.11%18.2M642.63%34.26M
Income tax 000-96.19%12K-100.63%-2K14K00315K315K
Net income -235.34%-7.53M-56.52%-7.77M-22.71%-7.11M-155.83%-9.99M-114.13%-4.8M222.73%5.56M-0.69%-4.96M12.19%-5.79M131.55%17.89M637.64%33.94M
Net income continuous Operations -235.34%-7.53M-56.52%-7.77M-22.71%-7.11M-155.83%-9.99M-114.13%-4.8M222.73%5.56M-0.69%-4.96M12.19%-5.79M131.55%17.89M637.64%33.94M
Minority interest income
Net income attributable to the parent company -235.34%-7.53M-56.52%-7.77M-22.71%-7.11M-155.83%-9.99M-114.13%-4.8M222.73%5.56M-0.69%-4.96M12.19%-5.79M131.55%17.89M637.64%33.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -235.34%-7.53M-56.52%-7.77M-22.71%-7.11M-155.83%-9.99M-114.13%-4.8M222.73%5.56M-0.69%-4.96M12.19%-5.79M131.55%17.89M637.64%33.94M
Basic earnings per share -211.54%-0.29-25.00%-0.3-3.57%-0.29-151.11%-0.46-112.88%-0.21218.18%0.264.00%-0.2420.00%-0.28123.56%0.9565.71%1.63
Diluted earnings per share -216.00%-0.29-25.00%-0.3-3.57%-0.29-152.87%-0.46-113.29%-0.21213.64%0.254.00%-0.2420.00%-0.28122.77%0.87551.43%1.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!